Name Oussaima Eldbouni Ahdab
Title Head of Infectious Diseases Division
Primary Specialty Infectious Diseases Consultant
Languages Arabic, English & French
Contact Details
Email [email protected]
Phone +974 4400 4400

Scope of Practice

  • Infectious Diseases specialist
  • Outpatients, In patients with acute and chronic infections ability to diagnose and treat
  • Prevention Diagnosis and management of Diseases caused by viral bacterial or parasitic infections
  • Management of complicated infections
  • Management of nosocomial infections
  • Travel medicine and Pre-travel guidance for infectious diseases
  • Adult Immunization program

Highlights

Academic Achievements:

0 +
Publications
0 +
Conferences

Community Outreach Activities/Achievements:

  • Director of vaccination center for COVID 19 at RHUH
  • Member of Leishmania program (at RHUH with Lebanese MOPH) treating and diagnosis

Health Care Profession Achievements:

  • +16 Years of Experience

Experience & Education

  • Infectious diseases Specialist Consultant
  • Program Director of Internal Medicine Department, Rafik Hariri University Hospital 
  • Research fellowship in HIV, Hôpital Cochin, Paris, France
  • Postgraduate diploma in Infection Control, Université Paris VII
  • Subspecialty training in HIV (Infectious diseases), Hôpital Saint Joseph, Paris, France
  • Post graduate diploma in Management of HIV patient, Université de Paris VII
  • AFSA (Attestation de Formation Spécialisée Approfondie) en Infectiologie, Hôpital Saint Joseph, Paris, France
  • Post graduate diploma in pathophysiology and therapeutics in infectious diseases, Université de Paris V
  • AFS (Attestation de formation Spécialisée) en Infectiologie
  • Fellowship-Infectious diseases, American University of Beirut, Lebanon
  • Fellowship -Internal Medicine, Lebanese university, Beirut, Lebanon
  • MD, 2000 Lebanese University, Beirut, Lebanon

Certifications & Memberships

  • Member of the LSID (Lebanese society of infectious diseases) 
  • Member of the ASM (American society for microbiology)
  • Member of FIDSA (member of IDSA)

Publications

Most Recent

  • Dipeptidyl peptidase III as a DNA marker to investigate epidemiology and taxonomy of Old World Leishmania species PLoS Negl Trop Dis 2021 Jul 26;15(7):e0009530. doi: 10.1371/journal.pntd.0009530. eCollection 2021 Jul.
  • Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP; HEPAVIH group. BMC Health Serv Res. 2012 Mar 12;12:59
  • Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G; ANRS CO-13 HEPAVIH Study Group. AIDS. 2012 Nov 13;26(17):2193-9
  • Kamel Mohammedi, Ronan Roussel, Oussaima El Dbouni, Louis Potier, Claire Fieschi, Emilie Capel, Corinne Vigouroux, Martine CaronDebarle, Jacqueline Capeau, Michel Marre. Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. J Clin Endocrinol Metab. 2011 Apr; 96(4):E653-7. Epub 2011 Jan 26.
  • Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008. Michel L, Villes V, Dabis F, Spire B, Winnock M, Loko MA, Poizot-Martin I, Valantin MA, Bonnard P, Salmon-Céron D, Carrieri MP; ANRS Co13 HEPAVIH Study Group. J Viral Hepat. 2010 Sep; 17 (9): 650-60
See more publications
  • Kanj SS, El-Dbouni O, Kanafani ZA, Araj GF.Susceptibility of respiratory pathogens to Gatifloxacin and other antimicrobial agents at the American University of Beirut Medical Center Int J Infect Dis. 2007 Nov;11(6):5546. Epub 2007 Mar 23
  • Traboulsi RS, Kattar MM, Dbouni O, Araj GF, Kanj SS. Fatal brain infection caused by Aspergillus glaucus in an immunocompetent patient identified by sequencing of the ribosomal 18S?28S internal transcribed spacer, European Journal of Clinical Microbiology & Infectious Diseases 2007 Oct;26(10):747-50.
  • Kanafani ZA, Dakdouki GK, El-Dbouni O, Bawwab T, Kanj SS. Surgical site infections following spinal surgery at a tertiary care center in Lebanon: incidence, microbiology, and risk factors. Scand J Infect Dis. 2006;38(8):589-92